RecallRadar

FDA Drug recall D-1733-2015

LIPOLEAN Injectable, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN

On 2015-09-23 the FDA classified a Class II recall of LIPOLEAN Injectable, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy, citing lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1733-2015
ClassificationClass II
Statusterminated
Initiated2015-06-02
Published2015-09-23
Last updated2026-09-13 11:51 UTC
CompanyThe Compounding Pharmacy
DistributionUS

Product

LIPOLEAN Injectable, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN

Reason

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Identifiers

code_info
All lots distributed between November 2014 and May 2015; 05082015@29, 8/6/2015; 04022015@43, 7/1/2015; 04242015@32,…All lots distributed between November 2014 and May 2015; 05082015@29, 8/6/2015; 04022015@43, 7/1/2015; 04242015@32, 7/23/2015; 04282015@37, 7/27/2015; 04292015@97, 7/28/2015; 04302015@61, 7/29/2015

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1733-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.